1. Home
  2. GKOS vs QBTS Comparison

GKOS vs QBTS Comparison

Compare GKOS & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$122.45

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo D-Wave Quantum Inc.

QBTS

D-Wave Quantum Inc.

HOLD

Current Price

$28.34

Market Cap

7.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
QBTS
Founded
1998
1999
Country
United States
United States
Employees
N/A
388
Industry
Medical/Dental Instruments
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
7.1B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
QBTS
Price
$122.45
$28.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
15
Target Price
$126.92
$32.53
AVG Volume (30 Days)
779.2K
24.8M
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.32
$81.05
Revenue Next Year
$27.43
$93.13
P/E Ratio
N/A
N/A
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$12.75
52 Week High
$148.11
$46.75

Technical Indicators

Market Signals
Indicator
GKOS
QBTS
Relative Strength Index (RSI) 40.86 68.53
Support Level $79.59 $26.37
Resistance Level $123.09 $30.77
Average True Range (ATR) 6.56 2.23
MACD -1.43 0.33
Stochastic Oscillator 5.60 77.63

Price Performance

Historical Comparison
GKOS
QBTS

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

Share on Social Networks: